๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Scleroderma

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies NCT01776398n/a1 site๐Ÿ“ New York Weill Medical College of Cornell University A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis. NCT07641634Phase 1, Phase 213 sites๐Ÿ“ Melbourne๐Ÿ“ Beijing๐Ÿ“ Guangzhou Prolium Bioscience, Inc ยท Tests: PRO-203, Placebo An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease NCT06379646NA1 site๐Ÿ“ Shanghai China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 CAR-T Cells Therapy for Patients With Autoimmune Diseases NCT07052565NA1 site๐Ÿ“ Hefei Anhui Provincial Hospital ยท Tests: Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy NCT07493395Phase 24 sites๐Ÿ“ Lille๐Ÿ“ Montpellier๐Ÿ“ Paris University Hospital, Montpellier ยท Tests: CD19 CAR T Arm Rare AutoImmune SElf-management Programme Development NCT06642870n/a1 site๐Ÿ“ Bristol University of the West of England ยท Tests: Non-interventional study Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases NCT07470151NA1 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: EVM18001 Injection Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases NCT06775912EARLY Phase 11 site๐Ÿ“ Lianyungang Nanjing Bioheng Biotech Co., Ltd. ยท Tests: RD06-05 CART Cell Injection Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases NCT07558850NA1 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: anti-CD19/BCMA-UCAR-T cells Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) NCT06350110Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: CD19- BCMA CAR-T cells Hormonal, Metabolic, and Signaling Interactions in PAH NCT01884051n/a1 site๐Ÿ“ Nashville Vanderbilt University Medical Center CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases NCT06941129Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: UCAR T-cell A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis NCT07497087Phase 3248 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Scottsdale Boehringer Ingelheim ยท Tests: Placebo matching nerandomilast formulation 1, Placebo matching nerandomilast formulation 2, Nerandomilast formulation 1โ€ฆ Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis NCT07360808NA2 sites๐Ÿ“ Guangzhou๐Ÿ“ Shanghai Cytori Therapeutics ยท Tests: Autologous ADRCs injection Combined with Standard Therapy, Standard Treatment group Rheumatology Diet Study NCT06339957n/a1 site๐Ÿ“ Orlando University of Central Florida Safety and Efficacy of Universal CD19-targeting CAR-ฮณฮดT Cells in Refractory Autoimmune Diseases NCT06828042Phase 1, Phase 21 site๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: anti-CD19 CAR T cell therapy Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases NCT06685042Phase 1, Phase 21 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: CAR T cell CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases NCT07315087Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: QT-019C Western Sweden Systemic Sclerosis Project NCT07345052n/a1 site๐Ÿ“ Gothenburg Sahlgrenska University Hospital ยท Tests: No Intervention: Observational Cohort New Orleans Pulmonary Hypertension Biobank NCT03269630n/a1 site๐Ÿ“ New Orleans Louisiana State University Health Sciences Center in New Orโ€ฆ ยท Tests: No intervention. Biospecimen collection only Safety, Efficacy and Cellular Metabolic Dynamics of CT1195E in Patients With Refractory / Progressive SSC NCT07355972EARLY Phase 11 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: CAR-T Therapy The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life NCT06675344NA4 sites๐Ÿ“ New Orleans๐Ÿ“ Ann Arbor๐Ÿ“ Pittsburgh Robyn T. Domsic, MD, MPH ยท Tests: Apollo Neuro Device, Sham device A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2) NCT06733935Phase 1, Phase 218 sites๐Ÿ“ Orange๐Ÿ“ Gainesville๐Ÿ“ Miami Nkarta, Inc. ยท Tests: NKX019, Fludarabine, Cyclophosphamide BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: BCMA-CD19 CAR-T therapy Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository NCT01808937n/a1 site๐Ÿ“ Dallas University of Texas Southwestern Medical Center ยท Tests: Morphea Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis NCT06954597Phase 26 sites๐Ÿ“ Bordeaux๐Ÿ“ La Tronche๐Ÿ“ Lille Topadur Pharma AG ยท Tests: TOP-N53, Sildenafil, TOP-N53 vehicle The Effect of Progressive Muscle Relaxation Exercises on Fatigue, Dyspnea, and Respiratory Function in Patients With Systemic Sclerosis NCT07842133NA1 site๐Ÿ“ Gaziantep University of Gaziantep ยท Tests: Progressive Muscle Relaxation Exercise Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases NCT05029336Phase 21 site๐Ÿ“ Philadelphia Stephan Grupp MD PhD ยท Tests: Depletion of CD3/CD19 in an autologous stem cell transplant CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease NCT07305116Phase 11 site๐Ÿ“ Hangzhou The Children's Hospital of Zhejiang University School of Meโ€ฆ ยท Tests: UCAR T-cell A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease NCT06189495Phase 24 sites๐Ÿ“ Beijing๐Ÿ“ Wuhan๐Ÿ“ Jinan Changchun GeneScience Pharmaceutical Co., Ltd. ยท Tests: GenSci048, GenSci048 placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy